Differential Effects of Cannabinoid Receptor 2 Agonists on HIV Replication and Inflammatory Activation in Monocyte-Derived Macrophages and Induced Pluripotent Stem Cell-Derived Microglia
Open Access
- 11 October 2025
- journal article
- research article
- Published by Springer Nature in Journal of Neuroimmune Pharmacology
- Vol. 20 (1) , 87
Abstract
Emerging evidence suggests brain-resident myeloid cells, including perivascular macrophages and microglia, provide a reservoir for HIV infection in the central nervous system (CNS), and their inflammatory activation is a proposed pathogenic mechanism in HIV-associated neurocognitive disorders (HAND). We investigated whether cannabinoid receptor 2 (CB2), an immunomodulatory receptor expressed in myeloid cells, regulates viral replication and inflammation in HIV-infected macrophages and microglia. Using the synthetic CB2-specific agonist JWH-133, we found that CB2 activation reduced HIV replication in primary human monocyte-derived macrophages (MDMs) and human induced pluripotent stem cell-derived microglia (iMg) at differing doses, corresponding to the basal expression of CNR2, which encodes CB2, and related endocannabinoid transcripts in each cell type. JWH-133 broadly reduced release of cytokines from HIV-infected MDMs but not iMg. RNA-seq revealed that CB2 agonism primarily altered interferon and integrated stress response pathways in MDMs while altering homeostatic pathways, including synapse maintenance and phagocytosis, in iMg. Further analyses in iMg revealed that NLRP3 inflammasome activation, but not priming, was reduced by CB2 activation, which did not inhibit HIV-induced nuclear factor kB activation. This study identifies key differences in CB2 response between myeloid lineage cell types and implicates CB2-specific agonists as promising candidates for the regulation of HIV-associated neuroinflammation. Graphical Abstract Created in BioRender. Espinoza, C. (2025) https://BioRender.com/mxfla3iKeywords
Funding Information
- National Institutes of Health (T32GM008076 and F31DA054001, R01DA057337 and R61DA058051, R21MH129193, P30AI045008)
This publication has 141 references indexed in Scilit:
- Neuroinflammatory responses from microglia recovered from HIV-1-infected and seronegative subjectsJournal of Neuroimmunology, 2005
- A Glial Endogenous Cannabinoid System Is Upregulated in the Brains of Macaques with Simian Immunodeficiency Virus-Induced EncephalitisJournal of Neuroscience, 2005
- Anandamide transport inhibitor AM404 and structurally related compounds inhibit synaptic transmission between rat hippocampal neurons in culture independent of cannabinoid CB1 receptorsEuropean Journal of Pharmacology, 2004
- Nef-Mediated Downregulation of CD4 Enhances Human Immunodeficiency Virus Type 1 Replication in Primary T LymphocytesJournal of Virology, 2002
- Differential expression of the CB2 cannabinoid receptor by rodent macrophages and macrophage-like cells in relation to cell activationInternational Immunopharmacology, 2002
- Determination of Coreceptor Usage of Human Immunodeficiency Virus Type 1 from Patient Plasma Samples by Using a Recombinant Phenotypic AssayJournal of Virology, 2001
- Activation of Human Microglial Cells by HIV-1 gp41 and Tat ProteinsClinical Immunology, 2000
- Human Immunodeficiency Virus Neurotropism: an Analysis of Viral Replication and Cytopathicity for Divergent Strains in Monocytes and MicrogliaJournal of Virology, 1998
- Role of immune activation and cytokine expression in HIV-1-associated neurologic diseasesAdvances in Neuroimmunology, 1995
- Downregulation of cell-surface CD4 expression by simian immunodeficiency virus Nef prevents viral super infection.Journal of Experimental Medicine, 1993